2.11
4.46%
0.09
Pre-mercato:
2.10
-0.010
-0.47%
Precedente Chiudi:
$2.02
Aprire:
$2.04
Volume 24 ore:
144.57K
Relative Volume:
0.91
Capitalizzazione di mercato:
$92.03M
Reddito:
$106.79M
Utile/perdita netta:
$-8.73M
Rapporto P/E:
-16.23
EPS:
-0.13
Flusso di cassa netto:
$10.81M
1 W Prestazione:
+1.44%
1M Prestazione:
-4.09%
6M Prestazione:
-25.96%
1 anno Prestazione:
-60.56%
Harvard Bioscience Inc Stock (HBIO) Company Profile
Nome
Harvard Bioscience Inc
Settore
Industria
Telefono
(508) 893-8999
Indirizzo
84 OCTOBER HILL RD, HOLLISTON, MA
Confronta HBIO con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
2.11 | 92.03M | 106.79M | -8.73M | 10.81M | -0.20 |
ISRG
Intuitive Surgical Inc
|
521.96 | 185.91B | 7.87B | 2.24B | 586.00M | 6.22 |
BDX
Becton Dickinson Co
|
226.87 | 65.59B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
84.89 | 41.99B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
228.69 | 33.57B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
327.56 | 23.72B | 2.88B | 499.60M | 321.60M | 6.74 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-03-10 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
2021-01-07 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
2020-12-09 | Iniziato | Northland Capital | Outperform |
2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
2019-07-08 | Downgrade | Janney | Buy → Neutral |
2018-01-24 | Reiterato | Janney | Buy |
2018-01-23 | Reiterato | The Benchmark Company | Buy |
2016-11-17 | Iniziato | Singular Research | Buy |
2015-07-28 | Iniziato | The Benchmark Company | Buy |
Mostra tutto
Harvard Bioscience Inc Borsa (HBIO) Ultime notizie
State Street Corp Acquires 7,763 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO stock touches 52-week low at $1.99 amid market challenges - Investing.com Nigeria
Lexaria Bioscience Forms Elite Scientific Advisory Board with Harvard Medical School Expert - StockTitan
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience - Yahoo Finance
BNP Paribas Financial Markets Has $201,000 Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
BNP Paribas Financial Markets Boosts Stock Position in Ovid Therapeutics Inc. (NASDAQ:OVID) - Defense World
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Update - Defense World
Harvard Bioscience (HBIO) Stock Dips Amid Industry Movements - GuruFocus.com
Harvard Bioscience (NASDAQ:HBIO) Stock Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Harvard Bioscience (HBIO) Stock Drops Amid Market Volatility - GuruFocus.com
3 US Penny Stocks With Market Caps Under $100M - Simply Wall St
Harvard Bioscience files $100M mixed securities shelf - MSN
In-Vitro and In-Vivo Micro Electrode Array Market to Grow by USD 7 Million (2024-2028), Driven by MEA Applications in Neuroscience Research, with AI Driving Market TransformationTechnavio - The Malaysian Reserve
272 Capital LP Has $1.54 Million Position in Harvard Bioscience, Inc. (NASDAQ:HBIO) - MarketBeat
Harvard Bioscience (HBIO) Stock Surges Amid Positive Analyst Rat - GuruFocus.com
HBIO stock touches 52-week low at $1.99 amid market challenges By Investing.com - Investing.com South Africa
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 13.8% in October - MarketBeat
Ayla Majid becomes first South Asian ACCA president - The Accountant Online
Harvard Bioscience (HBIO) Stock Drops Amid Industry Downturn - GuruFocus.com
272 Capital LP Increases Stake in Harvard Bioscience Inc - GuruFocus.com
HBIO stock touches 52-week low at $2.29 amid market challenges - Investing.com India
Harvard Bioscience (HBIO) Stock Dips Amid Market Volatility - GuruFocus.com
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript - Insider Monkey
Harvard Bioscience Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Harvard Bioscience (HBIO) Stock Surges with Positive Analyst Rat - GuruFocus.com
Harvard Bioscience Inc (HBIO) Quarterly 10-Q Report - Quartzy
SEC Form 10-Q filed by Harvard Bioscience Inc. - Quantisnow
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada
Harvard Bioscience: Q3 Earnings Snapshot - CT Insider
Harvard Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
3 Promising US Penny Stocks With At Least $100M Market Cap - Simply Wall St
Harvard Bioscience Inc Reports Q3 2024 Revenue of $22.0M, Misses Estimates; EPS Loss of $0.11 - GuruFocus.com
Harvard Bioscience : Q32024 HBIO Quarterly Earnings Presentation - Marketscreener.com
Harvard Bioscience Announces Third Quarter 2024 Financial Results - GlobeNewswire
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: W - GuruFocus.com
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Is It Too Late To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? - Yahoo Finance
Zacks Industry Outlook Highlights Mettler-Toledo International and Harvard Bioscience - Yahoo Finance
Harvard Bioscience (HBIO) Set to Announce Earnings on Thursday - MarketBeat
Moolec Science (MLEC) versus Its Rivals Head-To-Head Comparison - Defense World
Chegg, Inc. (NYSE:CHGG) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET - The Manila Times
Harvard Bioscience Inc Azioni (HBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):